UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System

Diabetes care, 2018-04, Vol.41 (4), p.789-796

2018

Volltextzugriff (PDF)

Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial

Diabetes technology & therapeutics, 2019-04, Vol.21 (4), p.159-169

2019

Volltextzugriff (PDF)

Closed loop control in adolescents and children during winter sports: Use of the Tandem Control‐IQ AP system

Pediatric diabetes, 2019-09, Vol.20 (6), p.759-768, Article pedi.12867

2019

Volltextzugriff (PDF)

Reply to Scaramuzza et al.: Comment on "Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes" by Messer et al

Diabetes technology & therapeutics, 2022-06, Vol.24 (6), p.458-459

Messer, Laurel H

2022

Volltextzugriff (PDF)

Why Expectations Will Determine the Future of Artificial Pancreas

Diabetes technology & therapeutics, 2018-06, Vol.20 (S2), p.S265-S2-68

Messer, Laurel H

2018

Volltextzugriff (PDF)

CGM Benefits and Burdens: Two Brief Measures of Continuous Glucose Monitoring

Journal of diabetes science and technology, 2019-11, Vol.13 (6), p.1135-1141

2019

Volltextzugriff (PDF)

The Increasing Onset of Type 1 Diabetes in Children

The Journal of pediatrics, 2012-10, Vol.161 (4), p.652-657.e1

2012

Volltextzugriff (PDF)

The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration

Pediatric diabetes, 2018-02, Vol.19 (1), p.14-17

2018

Volltextzugriff (PDF)

Hybrid Closed-Loop Systems to Date: Hype Versus Reality

Diabetes technology & therapeutics, 2023-01, Vol.25 (1), p.91-94

2023

Volltextzugriff (PDF)

A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm

Diabetes technology & therapeutics, 2019-08, Vol.21 (8), p.462-469

2019

Volltextzugriff (PDF)

Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2020-06, Vol.323 (23), p.2388

2020

Volltextzugriff (PDF)

Real world hybrid closed‐loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months

Pediatric diabetes, 2020-03, Vol.21 (2), p.319-327

2020

Volltextzugriff (PDF)

Six months of hybrid closed loop in the real‐world: An evaluation of children and young adults using the 670G system

Pediatric diabetes, 2020-03, Vol.21 (2), p.310-318

2020

Volltextzugriff (PDF)

Practical Implementation of Diabetes Technology: It Is Time

Diabetes technology & therapeutics, 2019-02, Vol.21 (S1), p.S148-S-159

Messer, Laurel H

2019

Volltextzugriff (PDF)

Real-World Diabetes Technology: Overcoming Barriers and Disparities

Diabetes technology & therapeutics, 2023-02, Vol.25 (S1), p.S176-S-190

2023

Volltextzugriff (PDF)

Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study

Diabetes care, 2017-12, Vol.40 (12), p.1644-1650

2017

Volltextzugriff (PDF)

Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2023-03, Vol.329 (12), p.990

2023

Volltextzugriff (PDF)

MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy

Expert review of medical devices, 2019-10, Vol.16 (10), p.845-853

2019

Volltextzugriff (PDF)

Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes

Diabetes technology & therapeutics, 2021-12, Vol.23 (12), p.837-843

2021

Volltextzugriff (PDF)

Preserving Skin Integrity with Chronic Device Use in Diabetes

Diabetes technology & therapeutics, 2018-06, Vol.20 (S2), p.S254-S2-64

2018

Volltextzugriff (PDF)

Real‐world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for hybrid closed‐loop use

Diabetes, obesity & metabolism, 2021-09, Vol.23 (9), p.2048-2057

2021

Volltextzugriff (PDF)

61-OR: Mobile Bolus Feature Improves Bolus Behavior in Control-IQ Users Who Bolus <3 Times/Day

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

154-LB: HEDIS Glycemic Goals Achieved by Control-IQ Technology Users across All Payer Types

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents and Potential Intervention Targets

Diabetes technology & therapeutics, 2020-10, Vol.22 (10), p.760-767

2020

Volltextzugriff (PDF)

Real-World Use of Control-IQ Technology Is Associated with a Lower Rate of Severe Hypoglycemia and Diabetic Ketoacidosis Than Historical Data: Results of the Control-IQ Observational (CLIO) Prospective Study

Diabetes technology & therapeutics, 2024-01, Vol.26 (1), p.24-32

2024

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(115)
Tagungsberichte
(1)

Sprache

Englisch
(116)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(89)
Life Sciences & Biomedicine
(87)
Endocrinology & Metabolism
(75)
Humans
(75)
Diabetes
(63)
Adolescent
(48)
Diabetes Mellitus, Type 1 - Drug Therapy
(44)
Type 1 Diabetes
(44)
Insulin
(42)
Diabetes Mellitus, Type 1 - Blood
(38)
Child
(37)
Female
(37)
Male
(36)
Pediatrics
(34)
Insulin Infusion Systems
(30)
Hypoglycemia
(29)
Adult
(28)
Diabetes Mellitus
(28)
Glucose
(28)
Glucose Monitoring
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System

Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial

Closed loop control in adolescents and children during winter sports: Use of the Tandem Control‐IQ AP system

Reply to Scaramuzza et al.: Comment on "Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes" by Messer et al

Why Expectations Will Determine the Future of Artificial Pancreas

CGM Benefits and Burdens: Two Brief Measures of Continuous Glucose Monitoring

The Increasing Onset of Type 1 Diabetes in Children

The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration

Hybrid Closed-Loop Systems to Date: Hype Versus Reality

A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm

Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial

Real world hybrid closed‐loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months

Six months of hybrid closed loop in the real‐world: An evaluation of children and young adults using the 670G system

Practical Implementation of Diabetes Technology: It Is Time

Real-World Diabetes Technology: Overcoming Barriers and Disparities

Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study

Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial

MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy

Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes

Preserving Skin Integrity with Chronic Device Use in Diabetes

Real‐world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for hybrid closed‐loop use

61-OR: Mobile Bolus Feature Improves Bolus Behavior in Control-IQ Users Who Bolus <3 Times/Day

154-LB: HEDIS Glycemic Goals Achieved by Control-IQ Technology Users across All Payer Types

Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents and Potential Intervention Targets

Real-World Use of Control-IQ Technology Is Associated with a Lower Rate of Severe Hypoglycemia and Diabetic Ketoacidosis Than Historical Data: Results of the Control-IQ Observational (CLIO) Prospective Study

Suchergebnisse filtern